[The safety and efficacy of basiliximab as induction agent in preventing early acute rejection in Chinese cardiac transplantation receipts].
Jie Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming-Zheng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Zhu(Sichuan University), Shengshou Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lihuan Li(Peking Union Medical College Hospital), Hong Zhao, Yun-hu Song, Yue-Jin Yang, Ping Liu(Shanghai University of Traditional Chinese Medicine), Zhe Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College)
PubMed
December 1, 2006
Cited by 0
Related Papers
The primary health-care system in China
|The Lancet|2017|1.1k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919
Pharmacological effects of Astragaloside IV: a literature review
|中医杂志：英文版|2013|263
High serum cortisol level is associated with increased risk of delirium after coronary artery bypass graft surgery: a prospective cohort study
|Critical Care|2010|187
Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage
|Frontiers in Pharmacology|2020|176